Metanephric osteopontin regulates nephrogenesis in vitro

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 41, Issue 4, 1997, Pages

  Rogers, Sharon A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751310561     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Brown, L. D L. Berse, A. Van De Water, C. A. PapadopoulosSegio, E. J. Perruzzi, E. J. Manseau, H. F. Dvorak and D. R. Spence. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell. 3:1169-1180,1992.
2. Denhardt, D. T and X. Guo. Osteopontin: a protein with diverse functions. FASEBJ. 7:1475-1482,1993.
3. Denhardt, D. T C. A. Lopez, E. E. Rollo, S. Hwang, X. An, and S. E. Walther. Osteopontin-induced modifications of cellular functions. Ann. NYAcad. Sci. 760:127-142,1995.
4. Gullberg, D and P. Ekblom. Extracellular matrix and its receptors during development. Int. J. Dev. Biol. 39: 845-854, 1995.
5. Hammerman, M. R S. A. Rogers, and G. Ryan. Growth factors and metanephrogenesis. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F523-F532,1992.
6. Hwang, S C. A. Lopez, D. E Heck, C. R Gardner, D. L Laskin, J. D Laskin J. D and D. T. Denhardt. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney. J. Biol. Chem. 269: 711-715,1995.
7. Kartha, S and F. G. Toback. Adenine nucleotides stimulate migration in wounded cultures of kidney epithelial cells. J. Clin. Invest. 90:288-292,1992.
8. Kiefer, M. C D. M. Bauer, and P. J. Barr. The cDNA and derived amino acid sequence for human osteopontin. Nucleic Acids Res. 17:3306,1989.
9. Kohri, K S. Nomura, Y. Kitamura, T. Nagata, M Yoshioka, T Iguchi, Y. Yamate, T. Imekawa, Y. Suzuki, H. Sinohara, and T. Kurita. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J. Biol. Chem. 268: 15 ISO15184, 1993.
10. LeBrun, D. P R. A. Warnke, and M. L. Cleary. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol. 142:743-753,1993.
11. Liaw, L M. Almedia C. E. Hart, S. M. Schwartz, and C. M. Giachelli. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 74: 214-224,1993.
12. Liaw, L M. P. Skinner, E. W. Raines, R. Ross, D. A. Cheresh, S. M. Schwartz, and C. M. Giachelli. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J. Clin. Invest. 95: 713-724,1995.
13. Miyauchi, A J. Alvarez, E. M. Greenfield, A. Teti, M. Grano, A. Colucci, A. Zambonin-Zallone, F. P. Ross, S. L. Teitelbaum, D. Cheresh, and K. A. Hruska. Recognition of osteopontin and related peptides by an av3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266: 2036920374,1991.
14. Noiri, E J. Gailit, D. Sheth, H. Magazine, M. Gurrath, G. Muller, Kessler, and M. S. Goligorsky. Cyclic RGD peptides ameliorate ischémie acute renal failure in rats. Kidney Int. 46: 1050-1058,1994.
15. Nomura, S A. J. Willis, D. R. Edwards, J. K Heath, and B. L. M. Hogan. Development expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106:441-450,1988.
16. Padanilam, B. J D. R. Martin, and M. R. Hammerman. Insulin-like growth factor I-enhanced renal expression of osteopontin following acute ischémie injury in rat. Endocrinology 137: 2133-2140,1996.
17. Pfaff, M K. Tangemann, B. Muller, M. Gurrath G. Muller, H. Kessler, R. Tïmpl, and J. Engel. Selective recognition of cyclic RGD peptides of NMR defined conformation by allbS, aV3, and a5l integrins. J. Biol. Chem. 269: 20233-20238, 1994.
18. Rodan, G. A. Osteopontin overview. Ann. NY Acad. Sci. 760: 1-5,1995.
19. Rogers, S. A G. Ryan, and M. R. Hammerman. Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro. J. Cell Biol. 113: 1447-1454,1991.
20. Rogers, S. A G. Ryan, A. F. Purchio, and M. R. Hammerman. Metanephric transforming growth factor-l regulates nephrogenesis in vitro. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F996-F1002,1993.
21. Ruoslahti, E and J. C. Reed. Anchorage dependence, integrins and apoptosis. Cell 77:477-478,1994.
22. Safirstcin, R. Gene expression in nephrotoxic and ischémie acute renal failure. J. Am. Soc. Nephrol. 4:1387-1395,1994.
23. Sariola, H. Does the kidney express redundant or important molecules during nephrogenesis? Exp. Nephrol. 4: 70-76,1996.
24. Saxen, L and H. Sariola. Early organogenesis of the kidney. Pediatr. Nephrol. 1:385-392,1987.
25. Schulte, B. A and S. S. Spicer. Histochemical evaluation of mouse and rat kidneys with lectin-horseradish peroxidase conjugates Am. J. Anat. 168:345-362,1983.
26. Sorenson, C. M S. A. Rogers, S. J Korsmeyer, and M. R. Hammerman. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F73-F81,1995.
27. Stern, D. N M. J. Glimcher, and R. A. Saavedra. Localization of osteopontin during mouse development. Ann. NY Acad. Sci. 760: 367-370,1995.
28. Wada, J A. Kumar, Z. Liu, E. Ruoslahti, L. Reichardt, J. Marvaldi, and Y. S. Kanwar. Cloning of the mouse integrin av-cDNAand role of the av-related matrix receptors in metanephric development. J. Cell Biol. 132:1161-1176,1996.
29. Weber, G. F S. Ashkar, M. J. Glimcher, and H. Cantor. Receptor-ligand interaction between CD44 and osteopontin (Eta1). Science 271:509-512,1996.
30. Zimolo, Z G. Wesolowski, H. Tanaka, J. Hyman, J. A. Hoyer, and G. A. Rodan. Soluble ocvs-integrin ligands raise [Ca2+]j in rat osteoclasts and mouse-derived osteoclast-like cells. Am. J. Physiol. 266 (Cell Physiol. 35): C376-C381,1994.